-
Research HighlightDecember 28, 2023Gene Expression Database for Mouse Development named a Global Core Biodata Resource
The Gene Expression Database for Mouse Development has been named a Global Core Biodata Resource in the 2023 selection round. -
Profile StoryJune 19, 2023What happens to the brain after a stroke?
Mary Teena Joy investigates what happens to the brain after a stroke and how to enhance brain neural rewiring to improve recovery. -
Press ReleaseFebruary 08, 2023JAX hires first chief data science officer
Paul Flicek, D.Sc., joins JAX as its inaugural chief data science officer to build a global data science initiative. -
Research HighlightDecember 11, 2018The unexpected advantages of outbred mice in research
Recently developed outbred mouse populations, such as the diversity outbred (DO) mice at The Jackson Laboratory (JAX), have created research options that parallel or even exceed human genetic diversity. Research with DO mice offers a full range of genetic diversity, and therefore more generalizability of responses across populations.
-
Featured ArticleOctober 24, 2023Applying AI and machine learning to complex research tasks
JAX researchers are at the forefront of developing and implementing AI-based technologies for a variety of research applications. -
Blog PostFebruary 27, 2023Examining the power and potential of the Cube
A synopsis of what The Cube Initiative is at JAX and why it may have a marked impact on the bridge between research and clinical application. -
Press ReleaseApril 13, 2021Shriners Hospitals for Children and JAX announce research affiliation
A new research affiliation agreement between Shriners Hospitals for Children (SHC) and JAX will endeavor to gain a greater understanding of the genetic factors involved in cerebral palsy. -
Search MagazineMarch 05, 2018Developing new therapies for Alzheimer’s disease
Alzheimer’s disease is still poorly understood despite its huge costs and burden. Greg Carter is working at the intersection between patient and mouse research to develop accurate disease models and develop effective therapies.